Basic Information
Glyphic Biotechnologies is a biotechnology startup focused on the field of proteomics. While DNA can reveal biological mysteries, proteins actually tell us what the body will do. We are developing an unprecedented next-generation protein sequencing platform, enabling researchers to gain new insights into biology and disease. The company's technology accelerates critical sequencing steps, with the potential to significantly shorten drug development time and bring its solutions to market.
Glyphic Biotechnologies, Inc.
SanFrancisco,California,United States of America
less than 15 people
January 01, 2021
letschat@glyphic.bio

